These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30358713)
1. Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy. Brinton LA; Brogan DR; Coates RJ; Swanson CA; Potischman N; Stanford JL Menopause; 2018 Nov; 25(11):1195-1200. PubMed ID: 30358713 [TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy. Brinton LA; Brogan DR; Coates RJ; Swanson CA; Potischman N; Stanford JL Menopause; 1998; 5(3):145-51. PubMed ID: 9774759 [TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes. Bassuk SS; Manson JE Ann Epidemiol; 2015 Mar; 25(3):193-200. PubMed ID: 25534509 [TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives and breast cancer. Brinton LA; Hoover R; Szklo M; Fraumeni JF Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784 [TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives as related to cancer and benign lesions of the breast. Fasal E; Paffenbarger RS J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801 [TBL] [Abstract][Full Text] [Related]
6. Menstrual factors in relation to breast cancer risk. Titus-Ernstoff L; Longnecker MP; Newcomb PA; Dain B; Greenberg ER; Mittendorf R; Stampfer M; Willett W Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):783-9. PubMed ID: 9752986 [TBL] [Abstract][Full Text] [Related]
7. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group. Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251 [TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives. Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556 [TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives and breast cancer: review of the epidemiologic literature. Thomas DB Contraception; 1991 Jun; 43(6):597-642. PubMed ID: 1868735 [TBL] [Abstract][Full Text] [Related]
11. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. La Vecchia C; Ron E; Franceschi S; Dal Maso L; Mark SD; Chatenoud L; Braga C; Preston-Martin S; McTiernan A; Kolonel L; Mabuchi K; Jin F; Wingren G; Galanti MR; Hallquist A; Lund E; Levi F; Linos D; Negri E Cancer Causes Control; 1999 Apr; 10(2):157-66. PubMed ID: 10231164 [TBL] [Abstract][Full Text] [Related]
12. Menopausal hormones and breast cancer in a biracial population. Moorman PG; Kuwabara H; Millikan RC; Newman B Am J Public Health; 2000 Jun; 90(6):966-71. PubMed ID: 10846517 [TBL] [Abstract][Full Text] [Related]
13. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years. Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204 [TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and breast cancer risk among younger women. Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232 [TBL] [Abstract][Full Text] [Related]
16. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546 [TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive agents and breast cancer: a population-based case-control study. Rohan TE; McMichael AJ Med J Aust; 1988 Nov; 149(10):520-6. PubMed ID: 3185321 [TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study. Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914 [TBL] [Abstract][Full Text] [Related]
19. 20. Oral contraceptives, hormone replacement therapy and breast cancer. Fentiman IS Int J Clin Pract; 2002 Dec; 56(10):755-9. PubMed ID: 12510949 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer before age 45 and oral contraceptive use: new findings. Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]